Refer to the Department of Neurology’s clinical trial page for a comprehensive listing.
About participating
What is a clinical trial? Clinical trials are organized experiments performed on human participants to determine the best way to treat, diagnose or prevent a disease. The information that scientists learn from clinical trials helps to improve the medical care for future patients. Clinical studies are carefully and ethically designed to protect participants from unnecessary side effects and other risks. Most clinical research is federally regulated with built-in safeguards to protect the participants.
An error has occurred, which probably means the feed is down. Try again later.
- Conditions: Systemic Lupus Erythematosus; Idiopathic Inflammatory Myopathy; Systemic Sclerosis; Rheumatoid Arthritis Interventions: Drug: CC-97540; Drug: Fludarabine; Drug: Cyclophosphamide; Drug: Tocilizumab Sponsors: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company; Bristol-Myers Squibb Services Unlimited Company Recruiting
- Conditions: Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE; Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM); Pediatric-Onset Multiple Sclerosis (POMS) Interventions: Biological: Moderna mRNA-1273; Biological: BNT162b2; Biological: Ad26.COV2.S; Drug: Continue IS (MMF or MPA); Drug: Continue IS (MTX); Biological: Continue IS (B cell depletion therapy); Biological: Monovalent [B.1.351] CoV2 preS dTM-AS03; Drug: Withhold IS (MMF or MPA); Drug: Withhold IS (MTX); Drug: Withhold IS (B cell depletion therapy); Biological: Moderna mRNA-1273, Bivalent; Biological: BNT162b2, Bivalent Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence; Rho Federal Systems […]
- Conditions: Duchenne Muscular Dystrophy Interventions: Genetic: SGT-003 Sponsors: Solid Biosciences Inc. Recruiting
- Conditions: Muscular Dystrophy, Duchenne Interventions: Genetic: delandistrogene moxeparvovec Sponsors: Sarepta Therapeutics, Inc.; Hoffmann-La Roche Recruiting
- Conditions: LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\) Sponsors: Nationwide Children's Hospital; National Institute of Neurological Disorders and Stroke (NINDS); Ann & Robert H Lurie Children's Hospital of Chicago; Children's Hospital Medical Center, Cincinnati; University of Iowa; Washington University School of Medicine; Stanford University; University of Utah; University of Rochester; University of Pittsburgh; University of Texas, Southwestern Medical Center at Dallas; University of Minnesota; University of California, Los Angeles; Boston Children's Hospital Recruiting
- Conditions: Frontotemporal Lobar Degeneration (FTLD); Progressive Supranuclear Palsy (PSP); Corticobasal Degeneration (CBD); Behavioral Variant Frontotemporal Dementia (bvFTD); Semantic Variant Primary Progressive Aphasia (svPPA); Nonfluent Variant Primary Progressive Aphasia (nfvPPA); FTD With Amyotrophic Lateral Sclerosis (FTD/ALS); Amyotrophic Lateral Sclerosis; Oligosymptomatic PSP (oPSP); C9orf72; GRN Related Frontotemporal Dementia; MAPT Gene Mutation; TBK1 Gene Mutation; Oligosymptomatic Progressive Supranuclear Palsy Sponsors: Mayo Clinic; University of California, San Francisco; National Institute on Aging (NIA); National Institute of Neurological Disorders and Stroke (NINDS) Recruiting
An error has occurred, which probably means the feed is down. Try again later.